StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lipella Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2025 was -$4.78M. For fiscal 2024 it was -$3.95M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$3.95M–
FY2023Dec 31, 2023-$3.15M–
FY2022Dec 31, 2022-$1.83M–
FY2021Dec 31, 2021-$989.27K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$926.06K–
Q2 FY2025Jun 30, 2025-$1.43M–
Q1 FY2025Mar 31, 2025-$1.43M–
Q4 FY2024Dec 31, 2024-$990.41K–
Q3 FY2024Sep 30, 2024-$653.10K–
Q2 FY2024Jun 30, 2024-$918.79K–
Q1 FY2024Mar 31, 2024-$1.39M–
Q4 FY2023Dec 31, 2023-$727.71K–
Q3 FY2023Sep 30, 2023-$689.36K–
Q2 FY2023Jun 30, 2023-$655.11K–
Q1 FY2023Mar 31, 2023-$1.08M–
Q4 FY2022Dec 31, 2022-$231.56K–
Q3 FY2022Sep 30, 2022-$320.21K–
Q2 FY2022Jun 30, 2022-$579.96K–
Q1 FY2022Mar 31, 2022-$699.43K–

More Lipella Pharmaceuticals figures

See a number that looks wrong?